A Day Up For InMed Pharmaceuticals Inc.
Mon, Mar 20, 2023 at 07:11 PM
InMed Pharmaceuticals Inc. (INM:NASDAQ) shot up at $1.46, representing a gain of 38.4%. On Mon, Mar 20, 2023, INM:NASDAQ hit a New 2-Week High of $1.46. The stock got featured on our News Catalysts scanner on Mon, Mar 13, 2023 at 08:42 AM in the 'BIOTECH' category. From Mon, Mar 06, 2023, the stock recorded 50.00% Up Days and 45.45% Green Days
The stock spiked on Wed, Jan 04, 2023 at $3.03 with a volume of 10M+.
About InMed Pharmaceuticals Inc. (INM:NASDAQ)
InMed Pharmaceuticals Inc is a Canada based pre-clinical stage biopharmaceutical company.
Top 10 Gainers:
- Loyalty Ventures Inc. (LYLT:NASDAQ), 153.78%
- Gelesis Holdings Inc. (GLS:NYSE), 90.82%
- Lifecore Biomedical Inc Com (LFCR:NASDAQ), 85.63%
- Ambipar Emergency Response Class A (AMBI:NYSEMKT), 71.99%
- GeneDx Holdings Corp Cl A (WGS:NASDAQ), 41.3%
- InMed Pharmaceuticals Inc. (INM:NASDAQ), 38.39%
- Allarity Therapeutics Inc. (ALLR:NASDAQ), 37.05%
- Biocept, Inc. (BIOC:NASDAQ), 35.84%
- Boxed Inc. (BOXD:NYSE), 35.74%
- SRAX, Inc. (SRAX:NASDAQ), 33.33%